Found: 32
Select item for more details and to access through your institution.
A case of mixed connective tissue disease complicated by pulmonary hypertension and ascites after addition of pulmonary vasodilators.
- Published in:
- Modern Rheumatology Case Reports, 2022, v. 6, n. 2, p. 203, doi. 10.1093/mrcr/rxac019
- By:
- Publication type:
- Article
A Japanese patient with anti-PM/Scl and centromere antibody-positive scleroderma-amyopathic dermatomyositis overlap syndrome who developed renal crisis.
- Published in:
- Modern Rheumatology Case Reports, 2022, v. 6, n. 1, p. 69, doi. 10.1093/mrcr/rxab025
- By:
- Publication type:
- Article
The two cases of acute acalculous cholecystitis associated with systemic lupus erythematosus (SLE) presented different clinical aspects.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Successful treatment with etanercept in a case of seronegative rheumatoid arthritis with corticosteroid/methotrexate-resistant pemphigus erythematosus.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Local Delivery of Mesenchymal Stem Cells with Poly-Lactic-Co-Glycolic Acid Nano-Fiber Scaffold Suppress Arthritis in Rats.
- Published in:
- PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0114621
- By:
- Publication type:
- Article
IL-17 Inhibits Chondrogenic Differentiation of Human Mesenchymal Stem Cells.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0079463
- By:
- Publication type:
- Article
The additive effects of hydroxychloroquine to maintenance therapy with standard of care in patients with systemic lupus erythematosus.
- Published in:
- International Journal of Rheumatic Diseases, 2020, v. 23, n. 4, p. 549, doi. 10.1111/1756-185X.13792
- By:
- Publication type:
- Article
Effectiveness and safety of hydroxychloroquine therapy with or without corticosteroid in patients with systemic lupus erythematosus.
- Published in:
- International Journal of Rheumatic Diseases, 2019, v. 22, n. 3, p. 434, doi. 10.1111/1756-185X.13387
- By:
- Publication type:
- Article
Discontinuation of adalimumab after attaining disease activity score 28-erythrocyte sedimentation rate remission in patients with rheumatoid arthritis (HONOR study): an observational study.
- Published in:
- Arthritis Research & Therapy, 2013, v. 15, n. 5, p. 1, doi. 10.1186/ar4315
- By:
- Publication type:
- Article
An elderly man with mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) without neuropsychiatric sequelae.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Safety and efficacy of anifrolumab therapy in systemic lupus erythematosus in real-world clinical practice: LOOPS registry.
- Published in:
- Rheumatology, 2024, v. 63, n. 9, p. 2345, doi. 10.1093/rheumatology/kead568
- By:
- Publication type:
- Article
Anti-survival motor neuron complex antibodies as a novel biomarker for pulmonary arterial hypertension and interstitial lung disease in mixed connective tissue disease.
- Published in:
- Rheumatology, 2024, v. 63, n. 4, p. 1068, doi. 10.1093/rheumatology/kead341
- By:
- Publication type:
- Article
Computed tomography for malignancy screening in patients with rheumatoid arthritis before initiation of disease modifying antirheumatic drug.
- Published in:
- Rheumatology, 2023, v. 62, n. 10, p. 3339, doi. 10.1093/rheumatology/kead075
- By:
- Publication type:
- Article
IL-6-accelerated calcification by induction of ROR2 in human adipose tissue-derived mesenchymal stem cells is STAT3 dependent.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
IL-6-accelerated calcification by induction of ROR2 in human adipose tissue-derived mesenchymal stem cells is STAT3 dependent.
- Published in:
- Rheumatology, 2014, v. 53, n. 7, p. 1282, doi. 10.1093/rheumatology/ket496
- By:
- Publication type:
- Article
Effects of tofacitinib on lymphocytes in rheumatoid arthritis: relation to efficacy and infectious adverse events.
- Published in:
- Rheumatology, 2014, v. 53, n. 5, p. 914, doi. 10.1093/rheumatology/ket466
- By:
- Publication type:
- Article
Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients—REACTION 52-week study.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients—REACTION 52-week study.
- Published in:
- Rheumatology, 2011, v. 50, n. 10, p. 1908, doi. 10.1093/rheumatology/ker221
- By:
- Publication type:
- Article
Activation of Syk in Peripheral Blood B Cells in Patients With Rheumatoid Arthritis: A Potential Target for Abatacept Therapy.
- Published in:
- Arthritis & Rheumatology, 2015, v. 67, n. 1, p. 63, doi. 10.1002/art.38895
- By:
- Publication type:
- Article
Correction: Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Efficacy and safety of high-dose of mycophenolate mofetil compared with cyclophosphamide pulse therapy as induction therapy in Japanese patients with proliferative lupus nephritis.
- Published in:
- Modern Rheumatology, 2022, v. 32, n. 6, p. 1077, doi. 10.1093/mr/roab113
- By:
- Publication type:
- Article
5-year remission rate after the discontinuation of adalimumab in patients with rheumatoid arthritis: Long-term follow-up results of the HONOR study.
- Published in:
- Modern Rheumatology, 2020, v. 30, n. 5, p. 799, doi. 10.1080/14397595.2019.1702141
- By:
- Publication type:
- Article
Association of the multi-biomarker disease activity score with joint destruction in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha inhibitor treatment in clinical practice.
- Published in:
- Modern Rheumatology, 2016, v. 26, n. 6, p. 850, doi. 10.3109/14397595.2016.1153449
- By:
- Publication type:
- Article
Clinically relevant radiographic progression in joint destruction in RA patients with abnormal MMP-3 or high levels of CRP despite 1-year treatment with infliximab.
- Published in:
- Modern Rheumatology, 2016, v. 26, n. 6, p. 807, doi. 10.3109/14397595.2016.1158386
- By:
- Publication type:
- Article
Effect of interleukin-6 receptor inhibitor, tocilizumab, in preventing joint destruction in patients with rheumatoid arthritis showing inadequate response to TNF inhibitors.
- Published in:
- Modern Rheumatology, 2014, v. 24, n. 3, p. 399, doi. 10.3109/14397595.2013.843757
- By:
- Publication type:
- Article
Efficacy and safety of reducing duration of infliximab infusion.
- Published in:
- Modern Rheumatology, 2014, v. 24, n. 2, p. 275, doi. 10.3109/14397595.2013.843747
- By:
- Publication type:
- Article
Abatacept inhibits radiographic progression in patients with rheumatoid arthritis: a retrospective analysis of 6 months of abatacept treatment in routine clinical practice. The ALTAIR study.
- Published in:
- Modern Rheumatology, 2014, v. 24, n. 1, p. 42, doi. 10.3109/14397595.2013.854051
- By:
- Publication type:
- Article
Efficacy and Safety of Biologics in Polymyalgia Rheumatica: A Retrospective Study.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 5, p. 1303, doi. 10.1007/s40744-024-00707-9
- By:
- Publication type:
- Article
Effectiveness and safety of mepolizumab in combination with corticosteroids in patients with eosinophilic granulomatosis with polyangiitis.
- Published in:
- Arthritis Research & Therapy, 2021, v. 23, n. 1, p. 1, doi. 10.1186/s13075-021-02462-6
- By:
- Publication type:
- Article
Comparative study of corticosteroid monotherapy, and TNF inhibitors with or without corticosteroid in patients with refractory entero-Behcet's disease.
- Published in:
- Arthritis Research & Therapy, 2019, v. 21, n. 1, p. N.PAG, doi. 10.1186/s13075-019-1933-8
- By:
- Publication type:
- Article
Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes.
- Published in:
- Arthritis Research & Therapy, 2022, v. 24, n. 1, p. 1, doi. 10.1186/s13075-022-02934-3
- By:
- Publication type:
- Article
Serum TNFα levels at 24 h after certolizumab pegol predict effectiveness at week 12 in patients with rheumatoid arthritis from TSUBAME study.
- Published in:
- Arthritis Research & Therapy, 2021, v. 23, n. 1, p. 1, doi. 10.1186/s13075-021-02547-2
- By:
- Publication type:
- Article